Malignant liver tumors.
Malignant tumors of the liver comprise a relatively small fraction of the total number of pediatric malignancies. However, these tumors can be a significant cause of morbidity and mortality, and there have been significant therapeutic gains during the past few decades through advances in systemic therapy and surgical treatment. Even in patients with advanced local disease, complete resection is now a possibility because of improvements in liver transplantation techniques. In this review, we will discuss the staging and treatment of common malignant tumors of the liver.
Pediatric Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York 10065, USA.
Joshua N
JN
Honeyman
Michael P
MP
La Quaglia
D000970:Antineoplastic Agents / Q000627:therapeutic use; D006528:Carcinoma, Hepatocellular / Q000473:pathology / Q000628:therapy; D017024:Chemotherapy, Adjuvant; D002648:Child; D002822:Choriocarcinoma / Q000556:secondary / Q000628:therapy; D005260:Female; D006498:Hepatectomy; D018197:Hepatoblastoma / Q000473:pathology / Q000628:therapy; D006801:Humans; D007680:Kidney Neoplasms / Q000473:pathology; D008113:Liver Neoplasms / Q000473:pathology / Q000556:secondary / Q000628:therapy; D020360:Neoadjuvant Therapy; D009367:Neoplasm Staging; D009447:Neuroblastoma / Q000556:secondary / Q000628:therapy; D011247:Pregnancy; D012509:Sarcoma / Q000473:pathology / Q000628:therapy; D014594:Uterine Neoplasms / Q000473:pathology; D009396:Wilms Tumor / Q000556:secondary / Q000628:therapy
D000970:Antineoplastic Agents